2.95
2.95 (0%)
As of Feb 14, 2025
Inspiremd, Inc. [NSPR]
Source:
Company Overview
Inspiremd, Inc is a medical device company focusing on the development and commercialization of products for the treatment of carotid artery disease and other vascular disease, including our proprietary CGuard™ stent platform.
| Country | Israel |
| Headquarters | tel aviv, israel |
| Phone Number | (888) 776-6804 |
| Industry | manufacturing |
| CEO | Marvin Slosman |
| Website | https://www.who.int |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $7 |
| Operating Profit | $-33.5 |
| Net Income | $-32 |
| Net Cash | $9.3 |
Profit Ratios
| Gross Margin | $1.5 |
| Operating Margin | -478 |
| Profit as % of Revenues | -4.7% |
| Profit as % of Assets | -67.8% |
| Profit as % of Stockholder Equity | -88.7% |
Management Effectiveness
| Return on Equity | -88.7% |
| Return on Assets | -68.4% |
| Turnover Ratio | 14.8% |
| EBITA | $-33.5 |
Balance Sheet and Cash Flow Measures
| Total Assets | $46.8 |
| Total Liabilities | $10.7 |
| Operating Cash Flow | $-21.9 |
| Investing Cash Flow | $12.6 |
| Financing Cash Flow | $18.5 |
